1255125007: Product containing precisely trastuzumab deruxtecan 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Phosphotransferase inhibitor-containing product\Protein kinase inhibitor-containing product\Epidermal growth factor receptor antagonist antineoplastic agent\Trastuzumab deruxtecan-containing product\Trastuzumab deruxtecan-containing product in parenteral dose form\Trastuzumab deruxtecan only product in parenteral dose form\Trastuzumab deruxtecan 100 mg powder for solution for infusion vial
• \Medicinal product categorised by disposition\Enzyme inhibitor-containing product\Transferase inhibitor-containing product\Phosphotransferase inhibitor-containing product\Protein kinase inhibitor-containing product\Epidermal growth factor receptor antagonist antineoplastic agent\Trastuzumab deruxtecan-containing product\Trastuzumab deruxtecan only product\Trastuzumab deruxtecan only product in parenteral dose form\Trastuzumab deruxtecan 100 mg powder for solution for infusion vial
• \Medicinal product categorised by disposition\Immunomodulator-containing product\Trastuzumab deruxtecan-containing product\Trastuzumab deruxtecan-containing product in parenteral dose form\Trastuzumab deruxtecan only product in parenteral dose form\Trastuzumab deruxtecan 100 mg powder for solution for infusion vial
• \Medicinal product categorised by disposition\Immunomodulator-containing product\Trastuzumab deruxtecan-containing product\Trastuzumab deruxtecan only product\Trastuzumab deruxtecan only product in parenteral dose form\Trastuzumab deruxtecan 100 mg powder for solution for infusion vial
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Polypeptide-containing product\Protein-containing product\Antibody-containing product\Monoclonal antibody-containing product\Monoclonal antibody antineoplastic agent\Trastuzumab deruxtecan-containing product\...
• \Trastuzumab deruxtecan-containing product in parenteral dose form\Trastuzumab deruxtecan only product in parenteral dose form\Trastuzumab deruxtecan 100 mg powder for solution for infusion vial
• \Trastuzumab deruxtecan only product\Trastuzumab deruxtecan only product in parenteral dose form\Trastuzumab deruxtecan 100 mg powder for solution for infusion vial
• \Medicinal product categorised by therapeutic role\Antineoplastic agent\...
• \Monoclonal antibody antineoplastic agent\Trastuzumab deruxtecan-containing product\...
• \Trastuzumab deruxtecan-containing product in parenteral dose form\Trastuzumab deruxtecan only product in parenteral dose form\Trastuzumab deruxtecan 100 mg powder for solution for infusion vial
• \Trastuzumab deruxtecan only product\Trastuzumab deruxtecan only product in parenteral dose form\Trastuzumab deruxtecan 100 mg powder for solution for infusion vial
• \Epidermal growth factor receptor antagonist antineoplastic agent\Trastuzumab deruxtecan-containing product\...
• \Trastuzumab deruxtecan-containing product in parenteral dose form\Trastuzumab deruxtecan only product in parenteral dose form\Trastuzumab deruxtecan 100 mg powder for solution for infusion vial
• \Trastuzumab deruxtecan only product\Trastuzumab deruxtecan only product in parenteral dose form\Trastuzumab deruxtecan 100 mg powder for solution for infusion vial
• \Product manufactured as parenteral dose form\Trastuzumab deruxtecan-containing product in parenteral dose form\Trastuzumab deruxtecan only product in parenteral dose form\Trastuzumab deruxtecan 100 mg powder for solution for infusion vial

Status: current, Defined. Date: 31-Oct 2022. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
5144509013	Trastuzumab deruxtecan 100 mg powder for solution for infusion vial	en	Synonym	Active	Case insensitive	SNOMED CT core
5144510015	Product containing precisely trastuzumab deruxtecan 100 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start